Svenska

Redeye: Challenging for Moberg Pharma to reach positive net earnings for the full year

Report this content

Moberg Pharma’s revenue in 2Q’17 was in line with our expectations, but higher OPEX resulted in EBITDA lower than our expectations and the consensus.

Read more and download the Research Update: https://www.redeye.se/company/moberg-pharma/560435/moberg-pharma-challenging-reach-positive-net-earnings-full-year#company-navigation

Start following companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. https://www.redeye.se/

Prenumerera